Vijay Satyanand Pande's most recent trade in Nautilus Biotechnology Inc was a trade of 45,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 14, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Nautilus Biotechnology Inc | Vijay Satyanand Pande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) |